Etiology and pathogenesis
The development of the disease is most often associated with two main factors: the presence of cholelithiasis in the patient (these conditions frequently coexist) and alcohol abuse.
The mechanism of organ damage in alcoholic etiology has a clear sequence. First, obstruction of the pancreatic ducts occurs, inevitably leading to their significant dilation. This is followed by atrophy of the parenchyma itself, active proliferation of fibrous tissue, and the formation of calcification foci. The ultimate outcome of this progression is the complete shutdown of the exocrine function of the organ, manifesting as severe digestive disorders in the form of maldigestion and malabsorption syndromes.
Clinical presentation
The course of the disease is undulating: periods of remission are replaced by exacerbations whose manifestations closely resemble an acute pancreatitis attack. Symptoms are generally divided into two large groups: manifestations during the exacerbation phase and syndromes of progressive functional loss.
Pain syndrome (during exacerbation):
- Triggers: heavy fatty meals or alcohol excess.
- Pain localization: epigastric region, left or right half of the abdomen. Sometimes the pain is atypical.
- Features: pain may persist for days and significantly intensifies after eating.
Exocrine and endocrine insufficiency: As the pancreas is destroyed, exocrine insufficiency syndrome develops. It manifests as steatorrhea (fatty stools), a tendency to persistent diarrhea due to impaired absorption, and a significant weight loss in the patient. Concurrently or shortly after, endocrine function suffers: first, glucose tolerance is impaired, and then full-blown diabetes mellitus develops.
In one-third of patients, the classic triad of symptoms can be detected:
- Pancreatic calcification.
- Diabetes mellitus.
- Steatorrhea.
Diagnostic procedures
To confirm the diagnosis, laboratory and instrumental methods are used:
- Laboratory diagnostics: a key marker of exacerbation is an elevated blood amylase level. However, it should be remembered that this spike may be short-lived.
- Instrumental Studies:
- Plain radiography: allows visualization of calcification areas in the projection of the pancreas.
- Ultrasound examination (ultrasound): reveals organ enlargement, expansion of its ductal system, presence of pseudocysts, and small foci of parenchymal calcification.
Treatment Management
Therapeutic measures pursue two main goals: reliable relief of pain and adequate replacement of lost pancreatic functions.
Non-pharmacological measures include strict and complete cessation of alcohol, frequent small meals, and a low-fat diet.
Pain management is built on a stepped approach. It starts with combinations of antispasmodics, anticholinergics, non-narcotic analgesics, and antidepressants. If this regimen fails, narcotic analgesics are used. An alternative method to reduce pain can be high doses of pancreatic enzymes.
Enzyme replacement therapy (ERT): The basis of exocrine insufficiency treatment is pancreatic extracts. A critically important rule: preparations must not contain bile acids, as they will undesirably stimulate the secretory activity of the diseased organ. To increase effectiveness, enzymes are combined with antacids or antisecretory drugs. This protects the medication from destruction in the acidic environment of the stomach and additionally reduces pancreatic stimulation. The success of ERT is assessed by the cessation of diarrhea, normalization of stool, and patient weight gain. In pronounced steatorrhea, fat-soluble vitamins (A, D, E, K) and B vitamins are also prescribed.
The treatment of endocrine insufficiency is carried out strictly according to standard management protocols for diabetes mellitus.
Briefly: answers to topical questions
What specific laboratory tests (besides amylase) are used to confirm exocrine pancreatic insufficiency?
To confirm exocrine pancreatic insufficiency, fecal elastase-1 testing and a coprogram are used.
- Fecal elastase-1 testing allows detection of primary exocrine insufficiency and assessment of its severity (at values less than 200 mcg/g).
- Coprogram is a laboratory method for assessing the digestive capacity of the gastrointestinal tract, revealing steatorrhea (high neutral fat content), creatorrhea (presence of undigested muscle fibers), and amylorrhea (excess starch).
What classifications of chronic pancreatitis exist?
There are several classification systems for chronic pancreatitis, including Marseille, Cambridge, M-ANNHEIM, TIGAR-O, as well as division by clinical and morphological features.
- TIGAR-O classification is an etiological system distinguishing toxic, idiopathic, hereditary, autoimmune, recurrent, and obstructive variants.
- By morphological features — interstitial-edematous, parenchymatous, fibro-sclerotic, hyperplastic, and cystic.
- By clinical course — rarely recurrent, frequently recurrent, and persistently symptomatic.
- By forms — combined and latent.
What complications can develop during the long-term course of chronic pancreatitis?
Chronic pancreatitis can lead to structural, inflammatory, vascular, and functional complications.
- Cystic formations — pancreatic pseudocysts, which may be asymptomatic or cause compression of neighboring organs; cysts are also mentioned among complications.
- Inflammatory processes — abscess, parapancreatitis, exudative pleurisy, paranephritis, pneumonia, "enzymatic" cholecystitis.
- Vascular disorders — pseudoaneurysm, splenic vein thrombosis, and infrahepatic portal hypertension.
- Patency disorders — impaired bile outflow and passage of duodenal contents.
- Endocrine disorders — pancreatogenic diabetes mellitus and hypoglycemic states.
The triad of chronic pancreatitis — "CPD": Calcification, Production of insulin decreased (Diabetes), Steatorrhea.
Class and exam questions
Why is it forbidden to take enzymes with bile acids in chronic pancreatitis?
Bile acids have a stimulating effect on the secretory activity of the pancreas. In chronic inflammation, such stimulation is undesirable as it can intensify pain and accelerate organ damage.
How to know if enzyme replacement therapy is properly selected?
The main clinical criteria for treatment effectiveness are the cessation of diarrhea, normalization of stool consistency (disappearance of steatorrhea), and stable weight gain in the patient.
What happens to blood amylase levels in this disease?
Amylase levels rise predominantly during exacerbation, when the clinical picture resembles acute pancreatitis. Outside of exacerbations or in late stages when the parenchyma is atrophied, amylase may remain normal.
What else to study on this topic
- Pathogenesis of alcoholic acinar cell damage
- Mechanisms of maldigestion and malabsorption development
- Step-wise pharmacotherapy regimen for pain syndrome
- Features of diet therapy in severe steatorrhea
- Ultrasound characteristics of pancreatic pseudocysts
Master the entire topic in the "Propaedeutics" course
This is a summary. The course covers everything tested in classes and exams.
- Full study guide on "Chronic pancreatitis" and 3,152 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 113 video lessons on the subject
Other topics in the "Digestive System" section
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.